# Inspired Entertainment, Inc.: financial statements, quarterly

INSE · Nasdaq · CIK 1615063 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inse.md) · [Financials](/companies/inse/financials.md) · [Filings](/companies/inse/filings.md) · [Insiders](/companies/inse/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inse/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [97.5](/filings/0001493152-24-044040.md) | [81.1 d](/filings/0001641172-25-000737.md) | [62.3](/filings/0001641172-25-009269.md) | [74.8](/filings/0001641172-25-022417.md) | [77.2](/filings/0001493152-25-020923.md) | [83.0 d](/filings/0001493152-26-025028.md) | [60.4](/filings/0001493152-26-021634.md) | [80.3](/filings/0001493152-26-036164.md) | [86.2](/filings/0001493152-25-020923.md) | [77.2 d](/filings/0001493152-26-025028.md) | [57.2](/filings/0001493152-26-021634.md) | [60.8](/filings/0001493152-26-036164.md) |
| Cost of revenue | $m | [21.4](/filings/0001493152-24-007977.md) | [71.7 d](/filings/0001641172-25-000737.md) | [15.9](/filings/0001493152-24-018572.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [23.6](/filings/0001493152-24-044040.md) | [30.9 d](/filings/0001493152-24-014609.md) | [31.9](/filings/0001493152-24-018572.md) | [29.2](/filings/0001493152-24-030805.md) | [29.6](/filings/0001493152-24-044040.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [12.2](/filings/0001493152-24-044040.md) | [8.3 d](/filings/0001641172-25-000737.md) | [(2.1)](/filings/0001641172-25-009269.md) | [8.7](/filings/0001641172-25-022417.md) | [11.2](/filings/0001493152-25-020923.md) | [12.9 d](/filings/0001493152-26-025028.md) | [1.6](/filings/0001493152-26-021634.md) | [7.9](/filings/0001493152-26-036164.md) | [9.7](/filings/0001493152-25-020923.md) | [11.3 d](/filings/0001493152-26-025028.md) | [9.2](/filings/0001493152-26-021634.md) | [9.9](/filings/0001493152-26-036164.md) |
| Interest expense | $m | [6.9](/filings/0001493152-24-007977.md) | [7.2 d](/filings/0001493152-24-014609.md) | [6.6](/filings/0001493152-24-018572.md) | [6.6](/filings/0001641172-25-022417.md) | [7.5](/filings/0001493152-25-020923.md) | [8.7 d](/filings/0001493152-26-025028.md) | [7.0](/filings/0001493152-26-021634.md) | [7.1](/filings/0001493152-26-036164.md) | [12.5](/filings/0001493152-25-020923.md) | [10.7 d](/filings/0001493152-26-025028.md) | [10.5](/filings/0001493152-26-021634.md) | [9.5](/filings/0001493152-26-036164.md) |
| Income tax | $m | [2.0](/filings/0001493152-24-044040.md) | [2.2 d](/filings/0001641172-25-000737.md) | [(2.1)](/filings/0001641172-25-009269.md) | [0.8](/filings/0001641172-25-022417.md) | [1.0](/filings/0001493152-25-020923.md) | [(62.6) d](/filings/0001493152-26-025028.md) | [(5.1)](/filings/0001493152-26-021634.md) | [8.8](/filings/0001493152-26-036164.md) | [(0.7)](/filings/0001493152-25-020923.md) | [8.1 d](/filings/0001493152-26-025028.md) | [(0.7)](/filings/0001493152-26-021634.md) | [0.4](/filings/0001493152-26-036164.md) |
| Net income | $m | [3.4](/filings/0001493152-24-044040.md) | [(0.7) d](/filings/0001641172-25-000737.md) | [(6.4)](/filings/0001493152-25-020923.md) | [1.4](/filings/0001493152-25-020923.md) | [2.8](/filings/0001493152-25-020923.md) | [67.0 d](/filings/0001493152-26-025028.md) | [(0.1)](/filings/0001493152-26-036164.md) | [(7.8)](/filings/0001493152-26-036164.md) | [(1.9)](/filings/0001493152-25-020923.md) | [(7.2) d](/filings/0001493152-26-025028.md) | [(0.5)](/filings/0001493152-26-036164.md) | [0.2](/filings/0001493152-26-036164.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001493152-24-044040.md) | not reported | [(0.22)](/filings/0001641172-25-009269.md) | [0.05](/filings/0001641172-25-022417.md) | [0.10](/filings/0001493152-25-020923.md) | not reported | [0.00](/filings/0001493152-26-021634.md) | [(0.27)](/filings/0001493152-26-036164.md) | [(0.07)](/filings/0001493152-25-020923.md) | not reported | [(0.02)](/filings/0001493152-26-021634.md) | [0.01](/filings/0001493152-26-036164.md) |
| Basic EPS | $ per share | [0.12](/filings/0001493152-24-044040.md) | not reported | [(0.22)](/filings/0001641172-25-009269.md) | [0.05](/filings/0001641172-25-022417.md) | [0.10](/filings/0001493152-25-020923.md) | not reported | [0.00](/filings/0001493152-26-021634.md) | [(0.27)](/filings/0001493152-26-036164.md) | [(0.07)](/filings/0001493152-25-020923.md) | not reported | [(0.02)](/filings/0001493152-26-021634.md) | [0.01](/filings/0001493152-26-036164.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.4](/filings/0001493152-24-044040.md) | [40.0](/filings/0001641172-25-000737.md) | [35.3](/filings/0001493152-24-018572.md) | [23.5](/filings/0001493152-24-030805.md) | [35.7](/filings/0001493152-25-020923.md) | [29.3](/filings/0001493152-26-025028.md) | [39.0](/filings/0001493152-26-021634.md) | [46.3](/filings/0001493152-26-036164.md) | [36.3](/filings/0001493152-25-020923.md) | [42.0](/filings/0001493152-26-036164.md) | [41.1](/filings/0001493152-26-021634.md) | [22.0](/filings/0001493152-26-036164.md) |
| Current assets | $m | [133](/filings/0001493152-24-007977.md) | [156](/filings/0001641172-25-000737.md) | [144](/filings/0001493152-24-018572.md) | [136](/filings/0001493152-24-030805.md) | [165](/filings/0001493152-24-044040.md) | [160](/filings/0001493152-26-025028.md) | [162](/filings/0001641172-25-009269.md) | [166](/filings/0001641172-25-022417.md) | [198](/filings/0001493152-25-020923.md) | [158](/filings/0001493152-26-036164.md) | [146](/filings/0001493152-26-021634.md) | [125](/filings/0001493152-26-036164.md) |
| Total assets | $m | [305](/filings/0001493152-24-007977.md) | [343](/filings/0001641172-25-000737.md) | [331](/filings/0001493152-24-018572.md) | [327](/filings/0001493152-24-030805.md) | [389](/filings/0001493152-24-044040.md) | [438](/filings/0001493152-26-025028.md) | [459](/filings/0001641172-25-009269.md) | [487](/filings/0001641172-25-022417.md) | [486](/filings/0001493152-25-020923.md) | [440](/filings/0001493152-26-036164.md) | [421](/filings/0001493152-26-021634.md) | [393](/filings/0001493152-26-036164.md) |
| Current liabilities | $m | [77.8](/filings/0001493152-24-007977.md) | [101](/filings/0001641172-25-000737.md) | [94.1](/filings/0001493152-24-018572.md) | [87.7](/filings/0001493152-24-030805.md) | [109](/filings/0001493152-24-044040.md) | [104](/filings/0001493152-26-025028.md) | [113](/filings/0001641172-25-009269.md) | [98.3](/filings/0001641172-25-022417.md) | [109](/filings/0001493152-25-020923.md) | [70.8](/filings/0001493152-26-036164.md) | [70.3](/filings/0001493152-26-021634.md) | [55.1](/filings/0001493152-26-036164.md) |
| Total liabilities | $m | [377](/filings/0001493152-24-007977.md) | [419](/filings/0001641172-25-000737.md) | [412](/filings/0001493152-24-018572.md) | [404](/filings/0001493152-24-030805.md) | [467](/filings/0001493152-24-044040.md) | [442](/filings/0001493152-26-025028.md) | [461](/filings/0001641172-25-009269.md) | [496](/filings/0001641172-25-022417.md) | [495](/filings/0001493152-25-020923.md) | [456](/filings/0001493152-26-036164.md) | [434](/filings/0001493152-26-021634.md) | [409](/filings/0001493152-26-036164.md) |
| Long-term debt | $m | [283](/filings/0001493152-24-007977.md) | [296](/filings/0001641172-25-000737.md) | [293](/filings/0001493152-24-018572.md) | [294](/filings/0001493152-24-030805.md) | [312](/filings/0001493152-24-044040.md) | [292](/filings/0001493152-26-025028.md) | [302](/filings/0001641172-25-009269.md) | [350](/filings/0001641172-25-022417.md) | [344](/filings/0001493152-25-020923.md) | [345](/filings/0001493152-26-036164.md) | [326](/filings/0001493152-26-021634.md) | [319](/filings/0001493152-26-036164.md) |
| Current portion of debt | $m | not reported | [19.1](/filings/0001641172-25-000737.md) | [18.9](/filings/0001493152-24-018572.md) | [19.0](/filings/0001493152-24-030805.md) | [20.1](/filings/0001493152-24-044040.md) | [18.8](/filings/0001493152-26-025028.md) | [19.4](/filings/0001641172-25-009269.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(72.5)](/filings/0001493152-24-044040.md) | [(75.9)](/filings/0001493152-26-025028.md) | [(80.3)](/filings/0001493152-25-020923.md) | [(77.1)](/filings/0001493152-25-020923.md) | [(78.2)](/filings/0001493152-25-020923.md) | [(3.3)](/filings/0001493152-26-036164.md) | [(2.2)](/filings/0001493152-26-036164.md) | [(9.5)](/filings/0001493152-26-036164.md) | [(9.0)](/filings/0001493152-25-020923.md) | [(16.2)](/filings/0001493152-26-036164.md) | [(12.4)](/filings/0001493152-26-036164.md) | [(15.6)](/filings/0001493152-26-036164.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.5 d](/filings/0001493152-24-044040.md) | [11.7 d](/filings/0001641172-25-000737.md) | [6.0](/filings/0001641172-25-009269.md) | [(2.4) d](/filings/0001641172-25-022417.md) | [21.2 d](/filings/0001493152-25-020923.md) | [6.9 d](/filings/0001493152-26-025028.md) | [25.5](/filings/0001493152-26-021634.md) | [15.2 d](/filings/0001493152-26-036164.md) | [10.1 d](/filings/0001493152-25-020923.md) | [1.2 d](/filings/0001493152-26-025028.md) | [26.7](/filings/0001493152-26-021634.md) | [2.8 d](/filings/0001493152-26-036164.md) |
| Capital expenditure | $m | [11.4 d](/filings/0001493152-24-044040.md) | [11.9 d](/filings/0001641172-25-000737.md) | [4.4](/filings/0001641172-25-009269.md) | [2.9 d](/filings/0001641172-25-022417.md) | [4.4 d](/filings/0001493152-25-020923.md) | [5.3 d](/filings/0001493152-26-025028.md) | [9.2](/filings/0001493152-26-021634.md) | [9.6 d](/filings/0001493152-26-036164.md) | [5.8 d](/filings/0001493152-25-020923.md) | [11.1 d](/filings/0001493152-26-025028.md) | [3.7](/filings/0001493152-26-021634.md) | [2.7 d](/filings/0001493152-26-036164.md) |
| Share repurchases | $m | [1.5 d](/filings/0001493152-24-044040.md) | [0.0 d](/filings/0001641172-25-000737.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.6](/filings/0001493152-26-021634.md) | [2.6 d](/filings/0001493152-26-036164.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.9](/filings/0001493152-24-007977.md) | [28.0](/filings/0001493152-24-018572.md) | [29.1](/filings/0001493152-24-030805.md) | [29.1](/filings/0001493152-24-044040.md) | [28.6](/filings/0001641172-25-009269.md) | [29.0](/filings/0001641172-25-022417.md) | [29.2](/filings/0001493152-25-020923.md) | [29.0](/filings/0001493152-26-021634.md) | [29.1](/filings/0001493152-26-036164.md) | [29.1](/filings/0001493152-25-020923.md) | [29.3](/filings/0001493152-26-021634.md) | [29.3](/filings/0001493152-26-036164.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,358,372 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001493152-26-036164.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.